EUVIMEDEUVIMED entdecken
Crossref

Real‐World Data on Quality of Life in Relation to the Type of Prophylaxis in Polish Children With Haemophilia A—A Nationwide Study

Klaudia Paczóska, Wanda Badowska, Halina Bobrowska, Łucja Dakowicz, Grzegorz Dobaczewski, Elżbieta Latos-Grażyńska, Grażyna Karolczyk, Anna Klukowska, Andrzej Kołtan, Magdalena Wojdalska, Paweł Łaguna, Danuta Pietrys und 12 weitere

Haemophilia · 2026

DOI: 10.1111/hae.70177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haemophilia, 2026. Verfasst von Klaudia Paczóska und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Hemato-Oncology, Pomeranian Medical University in Szczecin, Szczecin, Poland. Hauptthemen laut MEDLINE: Hemophilia A, Quality of Life, Factor VIII. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Takeda Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Modern prophylaxis in haemophilia aims not only to prevent bleeding but also to ensure a quality of life (QoL) comparable to healthy peers. Real‐world data on health‐related QoL (HRQoL) in children receiving personalised pharmacokinetic (PK)‐guided prophylaxis are limited.

Aim

To compare HRQoL outcomes in Polish children with haemophilia A who switched from standard plasma‐derived factor VIII (pdFVIII) prophylaxis to recombinant factor VIII (rFVIII), either as standard or PK‐tailored prophylaxis.

Methods

In this nationwide study, 131 boys with severe or moderate haemophilia A were assessed before and ≥26 weeks after switching from pdFVIII to rFVIII. Patients either continued standard prophylaxis (Group 1, n = 28) or started PK‐tailored prophylaxis (Group 2, n = 103). Bleeding outcomes (annualised bleeding rate [ABR], annualised joint bleeding rate [AJBR]) and QoL (EQ‐5D‐5L, Visual Analogue Scale [VAS]) were compared using Student's t ‐test and Wilcoxon test.

Results

Switching to rFVIII significantly reduced ABR (1.73→0.76; p = 0.004) and AJBR (0.65→0.33; p = 0.009). QoL improved overall, with higher VAS scores (88.6→91.2; p = 0.02) and lower EQ‐5D‐5L scores (5.78→5.54; p = 0.01). Improvements were most pronounced in Group 2, where both bleeding rates and QoL significantly improved, despite a higher weekly number of i.v. injections. No significant QoL changes were observed in Group 1.

Conclusion

Personalised PK‐based rFVIII prophylaxis leads to significant improvements in bleeding control and HRQoL in Polish children with haemophilia A. These results support the integration of PK‐guided prophylaxis into routine clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AQuality of LifeFactor VIIIHumansMalePolandChildChild, PreschoolAdolescentHemorrhage

Stichwörter der Autor:innen

childrenhaemophilia Apersonalised pharmacokinetic‐guided prophylaxisquality of life

Substanzen

Factor VIII

Autor:innen und Institutionen

  • Department of Pediatrics and Hemato-Oncology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Department of Pediatric Oncology and Hematology, School of Medicine, University of Warmia Mazury in Olsztyn, Olsztyn, Poland.
  • Wielkopolska Child Health Center, Poznan, Poland.
  • Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Białystok, Poland.
  • Department of Bone Marrow Transplantation, Pediatric Oncology and Hematology, Wroclaw Medical University, Wroclaw, Poland.
  • II Department of Pediatrics, Collegium Medicum, Jan Kochanowski University, Kielce, Poland.

Förderung

  • Takeda Pharmaceutical Company

Zitieren

APA

Paczóska, K., Badowska, W., Bobrowska, H., Dakowicz, Ł., Dobaczewski, G., Latos-Grażyńska, E., Karolczyk, G., Klukowska, A., Kołtan, A., Wojdalska, M., Łaguna, P., Pietrys, D., Radoń-Proskura, J., Radwańska, M., Rurańska, I., Szczepański, T., Wasiński, D., Woźnica-Karczmarz, I., Zielezińska, K., …, & Ociepa, T. (2026). Real‐World Data on Quality of Life in Relation to the Type of Prophylaxis in Polish Children With Haemophilia A—A Nationwide Study. Haemophilia. https://doi.org/10.1111/hae.70177

Vancouver

Paczóska K, Badowska W, Bobrowska H, Dakowicz Ł, Dobaczewski G, Latos-Grażyńska E, et al. Real‐World Data on Quality of Life in Relation to the Type of Prophylaxis in Polish Children With Haemophilia A—A Nationwide Study. Haemophilia. 2026. doi:10.1111/hae.70177

BibTeX
@article{Paczska2026,
  author = {Paczóska, Klaudia and Badowska, Wanda and Bobrowska, Halina and Dakowicz, Łucja and Dobaczewski, Grzegorz and Latos-Grażyńska, Elżbieta and Karolczyk, Grażyna and Klukowska, Anna and Kołtan, Andrzej and Wojdalska, Magdalena and Łaguna, Paweł and Pietrys, Danuta and Radoń-Proskura, Julia and Radwańska, Monika and Rurańska, Iwona and Szczepański, Tomasz and Wasiński, Dariusz and Woźnica-Karczmarz, Irena and Zielezińska, Karolina and Królak, Aleksandra and Bartnik, Magdalena and Kluk, Hubert and Urasiński, Tomasz and Ociepa, Tomasz},
  title = {Real‐World Data on Quality of Life in Relation to the Type of Prophylaxis in Polish Children With Haemophilia A—A Nationwide Study},
  journal = {Haemophilia},
  year = {2026},
  doi = {10.1111/hae.70177}
}
Kostenlos starten →